High Expression of Interleukin-22 and Its Receptor Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Expression of Interleukin-22 and Its Receptor Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
Authors
Keywords
Mantle Cell Lymphoma, Pancreatic Ductal Adenocarcinoma, PANC1 Cell, PDAC Cell, BxPC3 Cell
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue 1, Pages 125-132
Publisher
Springer Nature
Online
2013-10-16
DOI
10.1245/s10434-013-3322-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma
- (2014) Pascal Gelebart et al. Translational Oncology
- IL-22 is related to development of human colon cancer by activation of STAT3
- (2013) Runqiu Jiang et al. BMC CANCER
- Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2/STAT3/PI3K/Akt pathway in human gastric cancer cells
- (2013) Wei Xu et al. CANCER LETTERS
- p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth
- (2013) Mercedes Tkach et al. ENDOCRINE-RELATED CANCER
- STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer
- (2013) Yujuan Chen et al. Journal of Breast Cancer
- Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes
- (2013) Raghu Kadaba et al. JOURNAL OF PATHOLOGY
- Interaction of the Sympathetic Nerve with Pancreatic Cancer Cells Promotes Perineural Invasion through the Activation of STAT3 Signaling
- (2013) K. Guo et al. MOLECULAR CANCER THERAPEUTICS
- Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6->Androgen Receptor->TGF- ->MMP-9 Signals
- (2013) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival
- (2012) Yuan Zhuang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Demographics and Epidemiology of Pancreatic Cancer
- (2012) Theresa Pluth Yeo et al. CANCER JOURNAL
- Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells
- (2012) L. M. Curd et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial–mesenchymaltransition
- (2011) Wei Zhu et al. GUT
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice
- (2011) Hai dong Li et al. PLoS One
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts
- (2008) W. Zhang et al. CLINICAL CANCER RESEARCH
- Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer
- (2008) Zheng-Sheng Wu et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now